229 related articles for article (PubMed ID: 27846627)
21. Pathogenesis of Atopic Dermatitis: Current Paradigm.
Furue M; Ulzii D; Vu YH; Tsuji G; Kido-Nakahara M; Nakahara T
Iran J Immunol; 2019 Jun; 16(2):97-107. PubMed ID: 31182684
[TBL] [Abstract][Full Text] [Related]
22. Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells.
Wang YH; Ito T; Wang YH; Homey B; Watanabe N; Martin R; Barnes CJ; McIntyre BW; Gilliet M; Kumar R; Yao Z; Liu YJ
Immunity; 2006 Jun; 24(6):827-838. PubMed ID: 16782037
[TBL] [Abstract][Full Text] [Related]
23. The Role of Interleukins 4 and/or 13 in the Pathophysiology and Treatment of Atopic Dermatitis.
Silverberg JI; Kantor R
Dermatol Clin; 2017 Jul; 35(3):327-334. PubMed ID: 28577802
[TBL] [Abstract][Full Text] [Related]
24. IL-37 Targets TSLP-Primed Basophils to Alleviate Atopic Dermatitis.
Hou T; Tsang MS; Kan LL; Li P; Chu IM; Lam CW; Wong CK
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299012
[TBL] [Abstract][Full Text] [Related]
25. Adipose-derived stem cells attenuate atopic dermatitis-like skin lesions in NC/Nga mice.
Park HS; Son HY; Choi MH; Son Y; Kim S; Hong HS; Park JU
Exp Dermatol; 2019 Mar; 28(3):300-307. PubMed ID: 30688372
[TBL] [Abstract][Full Text] [Related]
26. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.
Suárez-Fariñas M; Dhingra N; Gittler J; Shemer A; Cardinale I; de Guzman Strong C; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2013 Aug; 132(2):361-70. PubMed ID: 23777851
[TBL] [Abstract][Full Text] [Related]
27. Gardenia jasminoides extract ameliorates DfE-induced atopic dermatitis in mice through restoration of barrier function and T-helper 2-mediated immune response.
Park SH; Jang S; Kim HK
Biomed Pharmacother; 2022 Jan; 145():112344. PubMed ID: 34847477
[TBL] [Abstract][Full Text] [Related]
28. Heat-shock pretreatment reduces expression and release of TSLP from keratinocytes under Th2 environment.
Kao JK; Lee CH; Lee MS; Hsu CS; Tsao LY; Tsai YG; Shieh JJ; Yang RC
Pediatr Allergy Immunol; 2016 Feb; 27(1):62-9. PubMed ID: 26419317
[TBL] [Abstract][Full Text] [Related]
29. Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model.
Hua C; Liang Q; Chen S; Zhu J; Tang Y; Chen X; Song Y; van der Veen S; Cheng H
Stem Cell Res Ther; 2023 May; 14(1):147. PubMed ID: 37248497
[TBL] [Abstract][Full Text] [Related]
30. Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice.
Jin W; Huang W; Chen L; Jin M; Wang Q; Gao Z; Jin Z
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544712
[TBL] [Abstract][Full Text] [Related]
31. Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy.
D'Erme AM; Romanelli M; Chiricozzi A
Drug Des Devel Ther; 2017; 11():1473-1480. PubMed ID: 28553077
[TBL] [Abstract][Full Text] [Related]
32. Innate Type 2 Response to
Park A; Lee E; Park H; Park MN; Lee J; Song KB; Yoon J; Jung S; Suh N; Yoon J; Yu J
J Korean Med Sci; 2021 Oct; 36(40):e261. PubMed ID: 34664800
[TBL] [Abstract][Full Text] [Related]
33. Current novel approaches in systemic therapy of atopic dermatitis: specific inhibition of cutaneous Th2 polarized inflammation and itch.
Werfel T; Biedermann T
Curr Opin Allergy Clin Immunol; 2015 Oct; 15(5):446-52. PubMed ID: 26308331
[TBL] [Abstract][Full Text] [Related]
34. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?
Guttman-Yassky E; Krueger JG
Curr Opin Immunol; 2017 Oct; 48():68-73. PubMed ID: 28869867
[TBL] [Abstract][Full Text] [Related]
35. Sophoricoside from Styphnolobium japonicum improves experimental atopic dermatitis in mice.
Kim BH; Lee S
Phytomedicine; 2021 Feb; 82():153463. PubMed ID: 33545490
[TBL] [Abstract][Full Text] [Related]
36. T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: at the origin of the problem.
Orciani M; Campanati A; Caffarini M; Ganzetti G; Consales V; Lucarini G; Offidani A; Di Primio R
Br J Dermatol; 2017 Jun; 176(6):1569-1576. PubMed ID: 27639070
[TBL] [Abstract][Full Text] [Related]
37. A CCR4 antagonist ameliorates atopic dermatitis-like skin lesions induced by dibutyl phthalate and a hydrogel patch containing ovalbumin.
Matsuo K; Hatanaka S; Kimura Y; Hara Y; Nishiwaki K; Quan YS; Kamiyama F; Oiso N; Kawada A; Kabashima K; Nakayama T
Biomed Pharmacother; 2019 Jan; 109():1437-1444. PubMed ID: 30551395
[TBL] [Abstract][Full Text] [Related]
38. TSLP Directly Interacts with Skin-Homing Th2 Cells Highly Expressing its Receptor to Enhance IL-4 Production in Atopic Dermatitis.
Tatsuno K; Fujiyama T; Yamaguchi H; Waki M; Tokura Y
J Invest Dermatol; 2015 Dec; 135(12):3017-3024. PubMed ID: 26288354
[TBL] [Abstract][Full Text] [Related]
39. Anti-TSLP antibodies: Targeting a master regulator of type 2 immune responses.
Nakajima S; Kabata H; Kabashima K; Asano K
Allergol Int; 2020 Apr; 69(2):197-203. PubMed ID: 31974038
[TBL] [Abstract][Full Text] [Related]
40. Improvement of atopic dermatitis-like skin lesions by Platycodon grandiflorum fermented by Lactobacillus plantarum in NC/Nga mice.
Kim MS; Kim WG; Chung HS; Park BW; Ahn KS; Kim JJ; Bae H
Biol Pharm Bull; 2012; 35(8):1222-9. PubMed ID: 22863917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
